| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $71.0M | -7.1% |
| SG&A Expense | $22.6M | +6.2% |
| Operating Income | -$93.6M | +4.2% |
| Pre-tax Income | -$89.6M | +1.1% |
| Income Tax | $49K | +107.9% |
| Net Income | -$89.7M | +0.4% |
| EPS (Basic) | -$2.12 | +25.6% |
| EPS (Diluted) | -$2.12 | +25.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.5M | +22.4% |
| Short-term Investments | $87.9M | +24.3% |
| Current Assets | $151.0M | +22.0% |
| Total Assets | $173.9M | +15.3% |
| Current Liabilities | $12.6M | -24.3% |
| Total Liabilities | $26.5M | -18.0% |
| Stockholders' Equity | $147.4M | +24.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.6M | +0.9% |
| Capital Expenditures | $264K | -46.9% |
| Investing Cash Flow | -$15.2M | +59.6% |
| Financing Cash Flow | $108.0M | +21.7% |
| Free Cash Flow | -$81.9M | +1.2% |